在风湿性疾病中加速输注利图西马布的安全性:系统性审查
Jozélio Freire de Carvalho1, Samuel de Oliveira Andrade2, Ana Tereza Amoedo Martinez3
1Núcleo de Pesquisa em Doenças Crônicas não Transmissíveis (NUPEC), School of Nutrition, Federal University of Bahia, Basílio da Gama, 200, Canela, Salvador, BA, 40110-040, Brazil. jotafc@gmail.com.
快速西马布 (RTX) 输注在自身免疫性类风湿性疾病中是安全和有效的,与标准剂量相比. 这种方法可以减少患者在诊所的时间,而不会增加输液反应,从而支持更广泛的风湿病学采用.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自身免疫性类风湿性疾病 (ARDs) 通常需要使用rituximab (RTX) 治疗.
- 标准的RTX输液方案对患者来说可能是耗时的.
- 评估加速输液协议对于提高患者的便利性和医疗保健效率至关重要.
更多相关视频
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
相关概念视频
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Myocarditis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
